Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
25/08/2026
|
5-day change | 1st Jan Change | ||
| 0.000700 USD | -12.50% |
|
-12.50% | -73.08% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 57.54M 53.92M 49.25M 92.94M 6.4B 93.86M 636M 248M 3.23B 252M 247M 10.7B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 130M 122M 111M 210M 14.46B 212M 1.44B 559M 7.3B 570M 557M 24.16B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | -12.50% | ||
| 1 week | -12.50% | ||
| Current month | +40.00% | ||
| 1 month | +75.00% | ||
| 3 months | +40.00% | ||
| 6 months | -85.42% | ||
| Current year | -73.08% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.1 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 9.31 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 01/04/2011 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2022 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 01/08/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.50% | -12.50% | -82.50% | -99.58% | 381K | |
| +3.31% | -3.70% | +61.03% | +103.64% | 71.35B | |
| +2.16% | +2.30% | +49.98% | +91.18% | 64.17B | |
| +1.09% | +22.96% | +8.55% | -3.03% | 28.65B | |
| -0.07% | -3.56% | -3.45% | +467.26% | 27.06B | |
| -2.78% | +5.95% | +55.58% | +12.15% | 27.33B | |
| -0.39% | +1.63% | +38.64% | -16.84% | 20.47B | |
| +1.02% | +6.43% | +269.42% | +420.34% | 19.36B | |
| -0.57% | -0.57% | +7.19% | +538.65% | 15.96B | |
| +3.98% | +6.78% | +49.66% | +157.94% | 14.05B | |
| Average | -0.48% | +2.77% | +45.41% | +167.17% | 28.84B | |
| Weighted average by Cap. | +1.33% | +3.31% | +55.66% | +155.15% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 45.33M 42.48M 38.8M 73.23M 5.04B 73.95M 501M 195M 2.54B 199M 194M 8.43B | 62.84M 53.85M 50.46M 46.09M 86.98M 5.99B 87.84M 595M 232M 3.02B 236M 231M 10.01B |
| Net income | -428M -367M -344M -314M -593M -40.83B -599M -4.06B -1.58B -20.6B -1.61B -1.57B -68.23B | -573M -491M -460M -420M -793M -54.61B -801M -5.43B -2.11B -27.55B -2.15B -2.1B -91.25B |
| Net Debt | 111M 94.85M 88.88M 81.19M 153M 10.55B 155M 1.05B 408M 5.32B 416M 407M 17.63B | 84.53M 72.43M 67.87M 61.99M 117M 8.06B 118M 801M 312M 4.07B 317M 310M 13.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/08/26 | $0.000700 | -12.50% | 332,415 |
| 24/08/26 | $0.000800 | 0.00% | 88,367 |
| 21/08/26 | $0.000800 | 0.00% | 39,050 |
| 20/08/26 | $0.000800 | 0.00% | 166,464 |
| 19/08/26 | $0.000800 | 0.00% | 51,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
